Activity of liver enzymes in multiple sclerosis patients with Hot-nature diet and co-supplemented hemp seed, evening primrose oils intervention

Complementary Therapies in Medicine

Volumn 22, Issue 6, 2014, Pages 986-993

  Rezapour Firouzi, Soheila ^a,b   Arefhosseini, Seyed Rafie ^a,b,e   Ebrahimi Mamaghani, Mehrangiz ^b   Baradaran, Behzad ^c   Sadeghihokmabad, Elyar ^a   Torbati, Mohammadali ^b   Mostafaei, Somaiyeh ^a   Chehreh, Mahtaj ^d   Zamani, Fatemeh ^c  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d ISLAMIC AZAD UNIVERSITY   (Iran)

^e TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Autoimmune liver dysfunction; Cannabis sativa L.; Inflammation; Oenothera biennis L.; PUFA; Side effects; Total antioxidant capacity

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; GAMMA GLUTAMYLTRANSFERASE; HEMP SEED OIL; OLIVE OIL; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; OMEGA 9 FATTY ACID; PRIMROSE OIL; UNCLASSIFIED DRUG; UNSATURATED FATTY ACID; VEGETABLE OIL; CANNABIS; GAMMA LINOLENIC ACID; LINOLEIC ACID;

ADULT; ARTICLE; CONTROLLED STUDY; DIET SUPPLEMENTATION; DIET THERAPY; DOUBLE BLIND PROCEDURE; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME BLOOD LEVEL; EVENING PRIMROSE; FATTY ACID SYNTHESIS; FEMALE; HOT NATURE DIET; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; RANDOMIZED CONTROLLED TRIAL; ADOLESCENT; DRUG EFFECTS; ENZYMOLOGY; LIVER; MIDDLE AGED; PLANT SEED; YOUNG ADULT;

ADOLESCENT; ADULT; CANNABIS; DOUBLE-BLIND METHOD; FEMALE; GAMMA-LINOLENIC ACID; HUMANS; LINOLEIC ACIDS; LIVER; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; PLANT OILS; SEEDS; YOUNG ADULT;

EID: 84912078943     PISSN: 09652299     EISSN: 18736963     Source Type: Journal    
DOI: 10.1016/j.ctim.2014.10.004     Document Type: Article

References (36)

1. Mao P., Reddy P.H. Is multiple sclerosis a mitochondrial disease?. Biochim Biophys Acta 2010, 1802:66-79.
2. Lublin F. History of modern multiple sclerosis therapy. J Neurol 2005, 252.
3. Pryse-Phillips W., Sloka J.S. Etiopathogenesis and epidemiolgy: clues to etiology. Handbook of multiple sclerosis 2006, 1-39. Taylor & Francis Group, New York, NY. S.D. Cook (Ed.).
4. Minagar A., Alexander J.S. Blood-brain barrier disruption in multiple sclerosis. Mult Scler 2003, 9:540-549.
5. McKenzie B.S., Kastelein R.A., Cua D.J. Understanding the IL-23-IL-17 immune pathway. Trends Immunol 2006, 27:17-23.
6. Harrington L.E., Hatton R.D., Mangan P.R. Interleukin17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 2005, 6:1123-1132.
7. Salem M.L. READAN. Immunomodulatory and antitumor effects of simultaneous treatment of mice with ω3 and ω6 polyunsatrated fatty acids. J Union Arab Biol 2000, 14A:489-505.
8. Shahabi S., Muhammad Hassan Z., Mahdavi M., Dezfoli M., Torabi Rahvar M., Naseri M., et al. Hot and Cold Natures and some parameters of neuroendocrine and immune systems in traditional Iranian medicine: a preliminary study. J Altern Complement Med 2008, 14(2):147-156.
9. Gallai V., Sarchielli V., Trequattrini A., Franceschini M., Floridi A., Firenzi C. Cytokine secretion and eicosanoid production in the peripheral blood mononuclear cells of MS patients undergoing dietary supplementation with omega-3 fatty acids. J Neuroimmunol 1995, 56:143-153.
10. Simopoulos A.P., Leaf A., Salem N. Workshop statement on the essentiality of and recommended dietary intakes from omega-6 and omega-3 fatty acids. Prostaglandins Leukot Essent Fatty Acids 2000, 63:119-121.
11. Matthaus B., Brühl L. Virgin hemp seed oil: an interesting niche product. Eur J Lipid Sci Technol 2008, 110:655-661.
12. Nissen L., Zatta A., Stefanini I., Grandi S., Sgorbati B., Biavati B., et al. Characterization and antimicrobial activity of essential oils of industrial hemp varieties (Cannabis sativa L.). Fitoterapia 2009, 7.
13. Oomah B.D., Busson M., Godfrey D.V., Drover J.C.G. Characteristic of hemp (Cannabis sativa L.) seed oil. Food Chem 2002, 76:33-43.
14. Horrobin D.F. Nutritional and medical importance of GAMA-linolenic acid. Prog Lipid Res 1992, 37:163-194.
15. Kurtzke J.F. Rating neurologic impairment in multiple sclerosis: an Expanded Disability Status Scale (EDSS). Neurology 1983, 33:1444-1452.
16. Mirzaei H. Multiple sclerosis 2010, Online document at w***ww.dr.myblog.ir/Post-1256.ASPX (accessed June 25, 2010), [in Persian].
17. Filippini G., Munari L., Incorvaia B., Ebers G.C., Polman C., D'Amico R., et al. Interferons in relapsing remitting multiple sclerosis: a systematic review. Lancet 2003, 361:545-552.
18. Callaway J.C. Hempseed as a nutritional resource: an overview. Euphytica 2004, 140:65-72.
19. Callaway J.C., Tennilä T., Pate D.W. Occurrence of "omega-3" stearidonic acid (cis-6,9,12,15-octadecatetraenoic acid) in hemp (Cannabis sativa L.) seed. J Int Hemp Assoc 1997, 3:61-63.
20. Kriese U., Schumann E., Weber W.E., Beyer M., Brühl L., Matthäus B. Oil content, tocopherol composition and fatty acid patterns of the seeds of 51 Cannabis sativa L. genotypes. Euphytica 2004, 137:339-351.
21. Sun A.Y., Wang Q., Simonyi A., Sun G.Y. Botanical phenolics and brain health. Neuromolecular Med 2008, 10(4):259-274.
22. Vivacons M., Moreno J.J. Beta-sitosterol modulates antioxidant enzyme response in RAW264.7 macrophages. Free Radic Biol Med 2005, 39:91-97.
23. van der Goes A., Brouwer J., Hoekstra K., Roos D., van den Berg T.K., Dijkstra C.D. Reactive oxygen species are required for the phagocytosis of myelin by macrophages. J Neuroimmunol 1998, 92:67-75.
24. Yoshida Y., Niki E. Antioxidant effects of phytosterol and its components. J Nutr Sci Vitaminol 2003, 49:277-280.
25. Taylor M. Alternative medicine and the perimenopause: an evidence-based review. Obstet Gynecol Clin North Am 2002, 29:555-573.
26. Horrobin D.F. Multiple sclerosis: the rational basis for treatment with colchicine and evening primrose oil. Med Hypotheses 1979, 5:365-378.
27. Esparza M.L., Sasaki S., Kesteloot H. Nutrition, latitude, and multiple sclerosis mortality: an ecologic study. Am J Epidemiol 1995, 142:733-737.
28. Morrell P., Quarles R.H. Myelin formation, structure and biochemistry 1999, 69-93. Philadelphia, PA.
29. Yehuda S., Rabinovitz S., Mostofsky D.I. Essential fatty acids and the brain: from infancy to aging. Neurobiol Aging 2005, 26S:S98-S102.
30. Lassmann H. Mechanisms of demyelination and tissue damage in multiple sclerosis. Acta Neurol Belg 1999, 99:6-10.
31. Delaleu N., Immervoll H., Cornelius J., Jonsson R. Biomarker profiles in serum and saliva of experimental Sjogren's Syndrome: associations with specific autoimmune manifestations. Arthritis Res Ther 2008, 10:R22.
32. Milijanovic B., Trivedi K., Dana M., Gilbard J., Buring J., Schaumberg D. Relation between dietary n-3 and n-6 fatty acids and clinically diagnosed dry eye syndrome in women. Am J Clin Nutr 2005, 82:887-893.
33. Kalman B., Laitinen K., Komoly S. The involvement of mitochondria in the pathogenesis of multiple sclerosis. J Neuroimmunol 2007, 188:1-12.
34. Brighenti F., Valtuena S., Pellegrini N., et al. Total antioxidant capacity of the diet is inversely and independently related to plasma concentration of high-sensitivity C-reactive protein in adult Italian subjects. Br J Nutr 2005, 93:619-625.
35. Mehta K., Van Thiel D.H., Shah N., Mobarhan S. Non-alcoholic fatty liver disease: pathogenesis and the role of antioxidants. Nutr Rev 2002, 60:289-293.
36. Zhong Z., Connor H.D., Froh M., et al. Free radical-dependent dysfunction of small-for-size rat liver grafts: prevention by plant polyphenols. Gastroenterology 2005, 129:652-664.